BioGaia (OM:BIOG B) - Aktienkurs, Nachrichten und Analyse

BIOG B Aktienübersicht

BioGaia AB (publ), ein Gesundheitsunternehmen, bietet weltweit probiotische Produkte an.

BIOG B grundlegende Analyse
Schneeflocken-Punktzahl
Bewertung	2/6
Künftiges Wachstum	2/6
Vergangene Leistung	2/6
Finanzielle Gesundheit	6/6
Dividenden	4/6

Belohnungen

Prognostiziertes Gewinnwachstum 10.22% pro Jahr

Risikoanalyse

Die Dividende von 5.61% ist durch den Cashflow nicht ausreichend gedeckt.

BioGaia AB (publ) Wettbewerber

Bonesupport Holding

OM:BONEX

SEK 17.3b

Swedish Orphan Biovitrum

OM:SOBI

SEK 96.4b

Biotage

OM:BIOT

SEK 13.0b

MedCap

OM:MCAP

SEK 7.4b

Preisentwicklung & Leistung

Übersicht über alle Höchststände, Veränderungen und Kursrückgänge für BioGaia
Historische Aktienkurse
Aktueller Aktienkurs	SEK 123.70
52-Wochen-Hoch	SEK 136.60
52-Wochen-Tief	SEK 91.45
Beta	0.54
11 Monat Veränderung	-1.36%
3 Monate Veränderung	-0.96%
1 Jahr Veränderung	6.64%
33 Jahre Veränderung	26.10%
5 Jahre Veränderung	52.15%
Veränderung seit IPO	1,465.83%

Aktuelle Nachrichten und Updates

BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90

Apr 25

BioGaia's (STO:BIOG B) Shareholders Will Receive A Bigger Dividend Than Last Year

Apr 09

BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90

Mar 26

BioGaia (STO:BIOG B) Will Pay A Larger Dividend Than Last Year At SEK6.90

Mar 09

Recent updates

BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90

Apr 25

BioGaia's (STO:BIOG B) Shareholders Will Receive A Bigger Dividend Than Last Year

Apr 09

BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90

Mar 26

BioGaia (STO:BIOG B) Will Pay A Larger Dividend Than Last Year At SEK6.90

Mar 09

BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90

Feb 24

Does This Valuation Of BioGaia AB (publ) (STO:BIOG B) Imply Investors Are Overpaying?

Jul 24

Calculating The Intrinsic Value Of BioGaia AB (publ) (STO:BIOG B)

Apr 02

BioGaia's (STO:BIOG B) Shareholders Will Receive A Bigger Dividend Than Last Year

Feb 21

Need To Know: Analysts Are Much More Bullish On BioGaia AB (publ) (STO:BIOG B) Revenues

Feb 09

BioGaia's (STO:BIOG B) Upcoming Dividend Will Be Larger Than Last Year's

Feb 07

Some Shareholders May find It Hard To Increase BioGaia AB (publ)'s (STO:BIOG B) CEO Compensation This Year

Apr 29

Key Things To Consider Before Buying BioGaia AB (publ) (STO:BIOG B) For Its Dividend

Mar 25

The BioGaia (STO:BIOG B) Share Price Is Up 90% And Shareholders Are Holding On

Mar 04

CEO & President Isabelle Valerie Ducellier Just Bought 8.2% More Shares In BioGaia AB (publ) (STO:BIOG B)

Feb 11

Is BioGaia AB (publ)'s (STO:BIOG B) Latest Stock Performance A Reflection Of Its Financial Health?

Jan 26

What Type Of Shareholders Own The Most Number of BioGaia AB (publ) (STO:BIOG B) Shares?

Jan 11

How Much Are BioGaia AB (publ) (STO:BIOG B) Insiders Taking Off The Table?

Dec 27

Read This Before Buying BioGaia AB (publ) (STO:BIOG B) For Its Dividend

Dec 13

BioGaia (STO:BIOG B) Shareholders Have Enjoyed A 57% Share Price Gain

Nov 28

Aktionärsrenditen

	BIOG B	SE Biotechs	SE Markt
7D	-1.2%	2.6%	-0.4%
1Y	6.6%	14.4%	12.9%

Rendite im Vergleich zur Industrie: BIOG B unter dem Niveau der Branche Swedish Biotechs , die im vergangenen Jahr eine Rendite von 16.6% erzielte.

Rendite vs. Markt: BIOG B hinter dem Markt Swedish zurück, der im vergangenen Jahr eine Rendite von 13.9 erzielte.

Preisvolatilität

Is BIOG B's price volatile compared to industry and market?
BIOG B volatility
BIOG B Average Weekly Movement	5.6%
Biotechs Industry Average Movement	8.9%
Market Average Movement	5.9%
10% most volatile stocks in SE Market	12.3%
10% least volatile stocks in SE Market	3.4%

Stabiler Aktienkurs: BIOG B hat in den letzten 3 Monaten keine nennenswerten Preisschwankungen aufgewiesen.

Volatilität im Zeitverlauf: BIOG BDie wöchentliche Volatilität (6%) ist im vergangenen Jahr stabil geblieben.

Über das Unternehmen

Gegründet	Mitarbeiter	CEO	Website
1990	211	Theresa Agnew	www.biogaia.com

BioGaia AB (publ), ein Gesundheitsunternehmen, bietet weltweit probiotische Produkte an. Das Unternehmen ist in den Segmenten Pädiatrie, Erwachsenengesundheit und Sonstige tätig. Das Segment Pädiatrie bietet Tropfen, orale Rehydrationslösungen und Darmgesundheitstabletten sowie Kulturen, die als Bestandteil von Säuglingsnahrung verwendet werden.

BioGaia AB (publ)'s Grundlagenzusammenfassung

Wie verhalten sich die Erträge und Einnahmen von BioGaia im Vergleich zum Marktanteil des Unternehmens?
BIOG B grundlegende Statistiken
Marktanteil	SEK 12.49b
Gewinn(TTM)	SEK 371.25m
Umsatz(TTM)	SEK 1.30b

33.6x

Kurs-Gewinn-Verhältnis

9.6x

Kurs-Umsatz-Verhältnis

Ist BIOG B zu teuer?

Siehe Fair Value und Bewertungsanalyse

Erträge & Einnahmen

Wichtige Rentabilitätsstatistiken aus dem letzten Ergebnisbericht (TTM)
BIOG B Gewinn- und Verlustrechnung (TTM)
Einnahmen	SEK 1.30b
Kosten der Einnahmen	SEK 346.97m
Bruttogewinn	SEK 953.51m
Sonstige Ausgaben	SEK 582.25m
Umsatz	SEK 371.25m

Zuletzt gemeldete Gewinne

Mar 31, 2024

Datum des nächsten Gewinnberichts

Jul 23, 2024

Gewinn per Aktie (EPS)	3.68
Bruttomarge	73.32%
Nettogewinnspanne	28.55%
Schulden/Eigenkapital-Verhältnis	0%

Wie hat sich BIOG B auf lange Sicht entwickelt?

Historische Performance und Vergleiche

Dividenden

5.6%

Aktuelle Dividendenrendite

52%

Ausschüttungsquote

BIOG B Aktienübersicht

Belohnungen

Risikoanalyse

BioGaia AB (publ) Wettbewerber

OM:BONEX

SEK 17.3b

OM:SOBI

SEK 96.4b

OM:BIOT

SEK 13.0b

OM:MCAP

SEK 7.4b

Preisentwicklung & Leistung

Aktuelle Nachrichten und Updates

First quarter 2024 earnings released: EPS: kr1.21 (vs kr1.15 in 1Q 2023)

BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90

BioGaia's (STO:BIOG B) Shareholders Will Receive A Bigger Dividend Than Last Year

Full year 2023 earnings: EPS and revenues exceed analyst expectations

BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90

BioGaia (STO:BIOG B) Will Pay A Larger Dividend Than Last Year At SEK6.90

Recent updates

First quarter 2024 earnings released: EPS: kr1.21 (vs kr1.15 in 1Q 2023)

BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90

BioGaia's (STO:BIOG B) Shareholders Will Receive A Bigger Dividend Than Last Year

Full year 2023 earnings: EPS and revenues exceed analyst expectations

BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90

BioGaia (STO:BIOG B) Will Pay A Larger Dividend Than Last Year At SEK6.90

BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90

Price target increased by 22% to kr140

BioGaia's (STO:BIOG B) Upcoming Dividend Will Be Larger Than Last Year's

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Biogaia AB (Publ) Proposes an Extra Dividend

Here's Why We Think BioGaia (STO:BIOG B) Might Deserve Your Attention Today

BioGaia AB (publ) to Report First Half, 2024 Results on Jul 07, 2024

Third quarter 2023 earnings released

BioGaia AB (publ), Annual General Meeting, Apr 26, 2024

Biogaia AB (Publ) Provides Preliminarily Earnings Guidance for Third Quarter 2023

Biogaia AB (Publ) Appoints Theresa Agnew as CEO

Calculating The Intrinsic Value Of BioGaia AB (publ) (STO:BIOG B)

BioGaia AB (publ) Introduces BioGaia Prodentis KIDS in Sweden

BioGaia Appoints Theresa Agnew as New CEO, Effective September 25, 2023

Second quarter 2023 earnings released

BioGaia's probiotic Protectis increases SARS-CoV-2 antibody response in adults

Does BioGaia (STO:BIOG B) Deserve A Spot On Your Watchlist?

Less than half of directors are independent

First quarter 2023 earnings released

BioGaia AB (Publ) Approves Dividend for 2022

Upcoming dividend of kr2.90 per share at 2.8% yield

A Look At The Intrinsic Value Of BioGaia AB (publ) (STO:BIOG B)

Full year 2022 earnings: EPS exceeds analyst expectations

Independent Director recently bought kr51k worth of stock

Price target increased by 9.1% to kr120

Full year 2022 earnings released: EPS: kr3.70 (vs kr1.94 in FY 2021)

BioGaia AB (publ) Proposes Ordinary Dividend

Do BioGaia's (STO:BIOG B) Earnings Warrant Your Attention?

Price target decreased to kr102

Third quarter 2022 earnings: Revenues exceed analyst expectations

Investor sentiment improved over the past week

BioGaia AB (publ) Provides Earnings Guidance for the Third Quarter of 2022

Do BioGaia's (STO:BIOG B) Earnings Warrant Your Attention?

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

Does This Valuation Of BioGaia AB (publ) (STO:BIOG B) Imply Investors Are Overpaying?

Biogaia AB (publ) Provides Earnings Guidance for the Second Quarter of 2022

Price target increased to kr620

BioGaia AB (publ) Approves Extra Dividend

First quarter 2022 earnings: Revenues exceed analyst expectations

Upcoming dividend of kr14.92 per share

Price target increased to kr570

BioGaia AB (publ) Provides Earnings Guidance for the First Quarter of 2022

BioGaia AB (publ) Proposes Dividend, Payable on 13 May 2022

Calculating The Intrinsic Value Of BioGaia AB (publ) (STO:BIOG B)

Full year 2021 earnings: EPS and revenues exceed analyst expectations

BioGaia's (STO:BIOG B) Shareholders Will Receive A Bigger Dividend Than Last Year

Consensus revenue estimates increase by 10%

Need To Know: Analysts Are Much More Bullish On BioGaia AB (publ) (STO:BIOG B) Revenues

BioGaia's (STO:BIOG B) Upcoming Dividend Will Be Larger Than Last Year's

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Biogaia AB (Publ) Proposes Ordinary Dividend

BioGaia's Probiotic Reduces Inflammation in Patients with Diverticulitis

BioGaia AB (publ) Announces First Patient Enrolled in Phase II Clinical Study Evaluating BGP345A for the Treatment of Opioid Induced Constipation (OIC-1)

Erträge & Einnahmen